Elevance Health Inc. (ELV) Cash Flow Statement

The $5.5B in claims paid in 2026Q2 is a fraction of the $41.1B paid in 2026Q1, reflecting typical quarterly seasonality. However, the sustained positive spread between premium collections and claims outflows suggests the core underwriting engine still generates cash, even as premium growth slows to 1.4% year-over-year. This float, combined with investment income, remains a key support for earnings and capital returns.

The extreme quarter-over-quarter variation in claims paid—an 87% drop—is unusual and may indicate that 2026Q1 included catch-up payments or a change in claims processing. Investors should monitor whether this volatility signals underlying utilization trends or simply timing. The prior income statement analysis noted an implausibly low loss ratio in 2026Q2, which aligns with the low claims paid, suggesting that reported underwriting profitability may be overstated if reserve releases are masking true claims experience.

In 2026Q1, purchases outpaced sales by $1.1B, but in 2026Q2, sales exceeded purchases by $1.1B, indicating a deliberate move to raise cash or rebalance the portfolio. This swing may reflect a need to fund operational cash shortfalls or a strategic repositioning. Given the modest investment income contribution typical for health insurers, the portfolio's role is more about liquidity management than earnings generation, and this shift warrants monitoring for any signs of stress.

The payout ratio (dividends plus buybacks divided by OCF) was approximately 32% in 2026Q2, well within a comfortable range. However, in quarters like 2025Q4, OCF was only $84M, while capital returns were $848M, forcing reliance on portfolio sales or cash reserves. This variability suggests that while the dividend is secure, buybacks may be opportunistic and dependent on cash generation, which has been uneven.

The wide swings in OCF/NI—from 0.15 to 2.63—suggest that reported net income is influenced by non-cash items such as reserve releases and investment gains. In 2026Q2, OCF/NI was 1.31, but the prior quarter's 2.46 and 2025Q4's 0.15 highlight the volatility. This inconsistency, combined with the anomalous loss ratio noted in the income statement analysis, suggests that investors should scrutinize the sustainability of earnings, as cash generation may not always support reported profitability.